Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...
UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europe from France’s Institut ...
Allied Bank (ABL) has delivered a 27.16% change over the past year, with a 52-week range between 122.00 and 219.80. What Is the Average Daily Trading Volume of Allied Bank (ABL)? The average daily ...
The ABL90 FLEX PLUS delivers lab-quality results at the point of care for more confident treatment decisions. Continuous automatic quality management (AQM) provides automatic quality control, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results